Tag Archives: Promega

Promega logo

Promega Signs Agreement With BrainXell

Promega signed a license agreement with BrainXell, a Madison-based producer of iPSC-derived human cells such as neurons and glia, the company announced today. “Reporter-enabled human neural models take expertise that…

Promega logo

Promega’s MSI Technology Receives FDA Approval

The U.S. Food and Drug Administration (FDA) approved the Promega OncoMate® MSI Dx Analysis System designed to identify patients with microsatellite high (MSI-H) solid tumors as a companion diagnostic designed…

Promega logo

Promega Achieves 100% Renewable Electricity

Promega achieved 100% renewable electricity across all global operations, the company announced today through its 2026 Corporate Responsibility Report. “Our 100% renewable electricity reflects years of deliberate investment, from solar…

Promega logo

Promega to Launch Cellular Target Engagement Technology

Promega is launching the TarSeer BRETSA Target Engagement System, a live-cell, target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins,…

Promega logo

Promega Study Advances Precision Medicine

Promega, alongside several research institutions, announced recently the publication of a new study in Nature Communications, highlighting technological advances that may accelerate breakthroughs in precision medicine. According to a release,…

Promega logo

Promega’s OncoMate Receives FDA Approval

The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable endometrial carcinoma who…

Promega logo

Promega, Watchmaker Genomics to Partner

Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase, the company announced today. According to a release, the enzyme will enhance Promega’s capabilities…

Promega logo

Promega Commits to SBTi

Promega has committed to set near-term company-wide emission reductions with the Science Based Targets initiative (SBTi), the company announced recently. According to a release, this commitment begins a defined process…

Promega logo

Promega, Longhorn Vaccines and Diagnostics to Partner

Promega and Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, are partnering, the companies recently announced. According to…

Promega logo

Promega, Addgene to Partner

Promega and Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, have partnered, the companies recently announced. According to a release, the partnership will expand…